Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bone marrow transplantation in leukemia.

E D Thomas

    Haematology and Blood Transfusion
    |January 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Marrow grafting offers a potential cure for acute leukemia patients, especially those who have relapsed. This established treatment shows promise for specific patient groups, with ongoing research addressing transplantation challenges.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The use of radiolabeled anti-CD33 antibody to augment marrow irradiation prior to marrow transplantation for acute myelogenous leukemia.

    Transplantation·1992
    Same author

    Methylation of the DXS255 hypervariable locus 5' CCGG site may be affected by factors other than X-chromosome activation status.

    Genomics·1992
    Same author

    Bone marrow transplantation: past experiences and future prospects.

    Seminars in oncology·1992
    Same author

    Donor alloreactivity may predict acute graft-versus-host disease in HLA-matched bone marrow transplantation for leukemia in early remission.

    European journal of haematology·1992
    Same author

    Mixed leukocyte culture reactivity and graft-versus-host disease in HLA-identical marrow transplantation for leukemia.

    Bone marrow transplantation·1992
    Same author

    Acceptance of the George M. Kober Medal.

    Transactions of the Association of American Physicians·1992
    Same journal

    Transferrin derivatives with growth factor activities in acute myeloblastic leukemia: an autocrine/paracrine pathway.

    Haematology and blood transfusion·1990
    Same journal

    Dependence of serum erythropoietin level on erythropoiesis in leukemia.

    Haematology and blood transfusion·1990
    Same journal

    Determination of soluble interleukin-2 receptors after bone marrow transplantation.

    Haematology and blood transfusion·1990
    Same journal

    Colony-stimulating factors (rhG-CSF, rhGM-CSF, rhIL-3, and BCGF) recruit myeloblastic and lymphoblastic leukemic cells and enhance the cytotoxic effects of cytosine-arabinoside.

    Haematology and blood transfusion·1990
    Same journal

    Interleukin-1 production in childhood acute lymphoblastic leukemia during chemo- and radiotherapy according to BFM (Berlin-Frankfurt-Münster) protocol.

    Haematology and blood transfusion·1990
    Same journal

    Complications of bone marrow transplantation in Chinese.

    Haematology and blood transfusion·1990
    See all related articles

    Area of Science:

    • Hematology
    • Oncology
    • Transplantation Immunology

    Background:

    • Marrow grafting is an established treatment for acute leukemia in patients under 50 with a suitable donor.
    • It offers a potential cure for approximately 20%-30% of relapsed acute leukemia patients, a cure rate not achievable by other regimens.
    • Marrow grafting is considered the treatment of choice for younger acute myeloid leukemia (ANL) patients in first remission, with a 50%-60% cure rate.

    Purpose of the Study:

    • To review the established role and potential of marrow grafting in acute leukemia treatment.
    • To highlight the challenges and progress in marrow grafting, focusing on disease eradication and transplantation immunobiology.

    Main Methods:

    • Review of established treatment protocols and outcomes for marrow grafting in acute leukemia.

    Related Experiment Videos

  • Analysis of current challenges including graft failure and immune rejection.
  • Discussion of ongoing research and advancements in the field.

    • Main Results:

    • Marrow grafting provides a cure for 20%-30% of relapsed acute leukemia patients.
    • For younger ANL patients in first remission, marrow grafting achieves a 50%-60% cure rate.
    • Key challenges remain in eradicating malignant disease and overcoming transplantation immunobiology.

    Conclusions:

    • Marrow grafting is a vital treatment option for specific acute leukemia patient populations.
    • Continued research and collaboration among transplant centers are crucial for overcoming current limitations.
    • Advancements in understanding and addressing transplantation immunobiology are expected to improve outcomes.